Status:
UNKNOWN
Effectiveness Study of Zymar Versus Vigamox for Preoperative Sterilization of the Ocular Surface After Loading Dose
Lead Sponsor:
Ophthalmic Consultants of Boston
Collaborating Sponsors:
Allergan
Conditions:
Eye Infection
Infection
Eligibility:
All Genders
25+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to analyze the effect of Zymar and Vigamox on ocular surface bacteria. We believe that Zymar will eradicate more ocular surface bacteria than Vigamox.
Detailed Description
Topical antibiotics are frequently used before surgical procedures with the intent of targetting and reducing the number of bacteria on the surface of the eye. These bacteria serve as potential source...
Eligibility Criteria
Inclusion
- Male or female 25 years of age or older
- Informed consent
- Likely to complete the entire course of the study
Exclusion
- Contraindications or known sensitivity to any component of the study medications
- A subject on oral or topical antibiotics
- A subject that has a condition (i.e. an uncontrolled systemic disease) or is in a situation which, in the investigator's opinion, may put the subject at significant risk, may confound the trial results, or may interfere significantly with the subject's participation in the trial.
- Monocular subjects
- Contact lens wearers
- Subjects who regularly take eyedrops other than preservative free artificial tears
- A subject with an eye infection
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
End Date :
June 1 2006
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00347828
Start Date
June 1 2006
End Date
June 1 2006
Last Update
July 4 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ophthalmic Consultants of Boston
Boston, Massachusetts, United States, 02114